AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ucoglim M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Smayan Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Ucoglim M 1mg/500mg Tablet SR

Diabetol Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetol Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended.

Primary Ingredients of Ucoglim M 1mg/500mg Tablet SR

No text was provided to rewrite.

Uses of Ucoglim M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Ucoglim M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Ucoglim M 1mg/500mg Extended-Release Tablet with food.

Common Side effects of Ucoglim M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ucoglim M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ucoglim M 1mg/500mg Sustained-Release Tablet with a meal.

How Ucoglim M 1mg/500mg Tablet SR works:

Ucoglim M SR tablets (1mg/500mg) contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Ucoglim M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Ucoglim M 1mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Ucoglim M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ucoglim M 1mg/500mg SR tablets cautiously, potentially requiring dose modification. Severe kidney disease contraindicates the use of Ucoglim M 1mg/500mg SR tablets. Physician consultation is recommended. Kidney function should be regularly monitored during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Ucoglim M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Ucoglim M 1mg/500mg Tablet SR :

Should you forget a dose of Ucoglim M 1mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ucoglim M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ucoglim M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Ucoglim M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Ucoglim M 1mg/500mg Tablet SR and seek immediate medical attention.
Ucoglim M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Ucoglim M 1mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Ucoglim M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Ucoglim M 1mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Ucoglim M 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Ucoglim M 1mg/500mg Table...
35
MRP 43
18% off